BRPI0917853A2 - composição farmacêutica, polímero reticulado de troca catiônica ou uma composição farmacêutica para remover potássio do trato gastrointestinal, polímetro carboxílico alifático reticulado estabilizado de poliol linear, e, método para fazer um polímetro reticulado de troca catiônica - Google Patents

composição farmacêutica, polímero reticulado de troca catiônica ou uma composição farmacêutica para remover potássio do trato gastrointestinal, polímetro carboxílico alifático reticulado estabilizado de poliol linear, e, método para fazer um polímetro reticulado de troca catiônica

Info

Publication number: BRPI0917853A2
Authority: BR; Brazil
Prior art keywords: cross; pharmaceutical composition; cation exchange; linked; polymer
Prior art date: 2008-08-22

Application number

BRPI0917853A

Other languages

English (en)

Inventor

Detlef Albrecht

Dominique Charmot

Eric Connor

Han-Ting Chang

I-Zu Huang

Jonathan Mills

Michael Burdick

Mingjun Liu

Paul Mansky

Ramakrishnan Chidambaram

Sherin Halfon

WERNER STRüVER

Original Assignee

Relypsa Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-22

Filing date

2009-08-22

Publication date

2015-11-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41707686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917853(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-08-22 Application filed by Relypsa Inc filed Critical Relypsa Inc

2015-11-24 Publication of BRPI0917853A2 publication Critical patent/BRPI0917853A2/pt

2020-04-07 Publication of BRPI0917853B1 publication Critical patent/BRPI0917853B1/pt

2020-04-22 Publication of BRPI0917853B8 publication Critical patent/BRPI0917853B8/pt

2021-05-25 Publication of BRPI0917853C1 publication Critical patent/BRPI0917853C1/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/16—Organic material
- B01J39/18—Macromolecular compounds
- B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/34—Monomers containing two or more unsaturated aliphatic radicals
- C08F212/36—Divinylbenzene

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Vascular Medicine (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Processes Of Treating Macromolecular Substances (AREA)

BRPI0917853A 2008-08-22 2009-08-22 polímero reticulado de troca catiônica BRPI0917853C1 (pt)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US9109708P	2008-08-22	2008-08-22
US9111008P	2008-08-22	2008-08-22
US9112508P	2008-08-22	2008-08-22
US16589409P	2009-04-01	2009-04-01
US16589909P	2009-04-01	2009-04-01
US16590509P	2009-04-02	2009-04-02
PCT/US2009/054706 WO2010022383A2 (en)	2008-08-22	2009-08-22	Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia

Publications (4)

Publication Number	Publication Date
BRPI0917853A2 true BRPI0917853A2 (pt)	2015-11-24
BRPI0917853B1 BRPI0917853B1 (pt)	2020-04-07
BRPI0917853B8 BRPI0917853B8 (pt)	2020-04-22
BRPI0917853C1 BRPI0917853C1 (pt)	2021-05-25

Family

ID=41707686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0917853A BRPI0917853C1 (pt)	2008-08-22	2009-08-22	polímero reticulado de troca catiônica

Country Status (26)

Country	Link
US (4)	US20110236340A1 (pt)
EP (4)	EP3431094B1 (pt)
JP (7)	JP5756403B2 (pt)
KR (5)	KR102300471B1 (pt)
CN (2)	CN103919792B (pt)
AU (1)	AU2009282721B2 (pt)
BR (1)	BRPI0917853C1 (pt)
CA (1)	CA2735058C (pt)
CY (3)	CY2018002I1 (pt)
DE (1)	DE112009002063T5 (pt)
DK (3)	DK2365988T4 (pt)
ES (4)	ES2699494T3 (pt)
FI (1)	FI3431094T3 (pt)
GB (4)	GB2475657B (pt)
HR (4)	HRP20230091T1 (pt)
HU (4)	HUE061320T2 (pt)
LT (4)	LT2957286T (pt)
LU (1)	LUC00094I2 (pt)
MX (3)	MX389664B (pt)
NL (1)	NL300962I2 (pt)
NO (2)	NO2018004I1 (pt)
PL (4)	PL2957286T3 (pt)
PT (3)	PT2957286T (pt)
SI (2)	SI2957286T1 (pt)
SM (2)	SMT201800660T1 (pt)
WO (1)	WO2010022383A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8574716B2 (en) *	2006-01-23	2013-11-05	Hitachi Chemical Co., Ltd.	Ionic polymer devices and methods of fabricating the same
EP3431094B1 (en)	2008-08-22	2022-12-07	Vifor (International) Ltd.	Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
WO2010022380A2 (en)	2008-08-22	2010-02-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
CN102844334A (zh) *	2010-03-20	2012-12-26	瑞立普萨公司	用于制备聚氟代丙烯酸酯粒子的连续方法
FI2673237T4 (fi)	2011-02-11	2025-12-12	Zs Pharma Inc	Zirkoniumsilikaatin käyttö hyperkalemian hoitamiseen
ES2758708T3 (es)	2011-06-27	2020-05-06	Relypsa Inc	Fluoración de ésteres de acrilato y derivados
ES2895909T3 (es)	2011-06-27	2022-02-23	Vifor Pharma Tech Ltd	Procedimiento para la conversión de un éster polimérico a un ácido polimérico
CN105451746A (zh) *	2012-07-19	2016-03-30	瑞立普萨公司	包含交联阳离子结合聚合物的组合物
EP2882798B1 (en)	2012-08-09	2019-05-08	Patheon Austria GmbH & Co KG	Process for drying polymeric materials
CN104822383A (zh)	2012-10-08	2015-08-05	瑞立普萨公司	治疗高血压和高血钾症的钾结合剂
US10695365B2 (en)	2012-10-22	2020-06-30	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
CA2908641C (en) *	2013-04-05	2022-10-18	ZS Pharma, Inc.	Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease
CA2971725C (en) *	2014-12-23	2024-05-14	Ardelyx, Inc.	Compositions and methods for treating hyperkalemia
JP6624704B2 (ja)	2015-08-31	2019-12-25	日立化成株式会社	尿路上皮疾患の評価のための分子法
US9592253B1 (en)	2015-10-14	2017-03-14	ZS Pharma, Inc.	Extended use zirconium silicate compositions and methods of use thereof
ITUB20159278A1 (it)	2015-12-23	2017-06-23	Rjw Pharma Llc	Procedimento per la sintesi di patiromer
WO2019220450A1 (en)	2018-05-16	2019-11-21	Solara Active Pharma Sciences Limited	Process for preparation of patiromer
JP2022524454A (ja) *	2019-03-13	2022-05-02	アストラゼネカ・アクチエボラーグ	血液透析患者に使用するカリウム結合剤
WO2021097012A1 (en) *	2019-11-14	2021-05-20	Relypsa, Inc.	One step synthesis for alkyl 2-fluoroacrylates
CN115427383B (zh)	2020-03-27	2025-08-26	维福(国际)有限公司	2-氟丙烯酸甲酯的合成
EP4171582B1 (en) *	2021-09-13	2024-03-13	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Polymer medicament for treating hyperkalemia and preparation method thereof
US20240139234A1 (en) *	2021-11-17	2024-05-02	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Pharmaceutical polymer for treating hyperkalemia and preparation method thereof
CN114369729B (zh) *	2021-12-28	2023-11-03	江苏容汇通用锂业股份有限公司	一种利用锂矿渣进行浸出液除钾的工艺
CN114394918B (zh) *	2022-01-19	2023-10-20	罗长青	一种2-[[三(羟甲基)甲基]氨基]乙磺酸的制备方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2611730A (en) *	1950-09-02	1952-09-23	Simth Kline & French Lab	Medical preparation for reducing the body level of sodium
US2909462A (en) *	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
US3499960A (en) *	1965-01-25	1970-03-10	Merck & Co Inc	Palatable coated particles of an anion exchange resin
NL137053C (pt) †	1967-01-30
FR2171934B1 (pt) *	1972-02-16	1974-09-13	Rhone Poulenc Sa
US3974272A (en) *	1972-09-01	1976-08-10	Merck & Co., Inc.	Palatable cholestyramine coacervate compositions
US4143130A (en) *	1977-08-29	1979-03-06	Warren-Teed Laboratories, Inc.	Method for treating kidney stones
US4470975A (en) *	1977-10-21	1984-09-11	The Johns Hopkins University	Method and composition for the elimination of water from an animal body
US4380590A (en) *	1978-09-19	1983-04-19	Rohm And Haas Company	Emulsion copolymer cation exchange resins
DE2846187A1 (de) †	1978-10-24	1980-05-08	Bayer Ag	Kunstharze auf basis vernetzter mischpolymerisate aus mono- und polyvinylverbindungen
JPS6090243A (ja) *	1983-10-25	1985-05-21	Nitto Boseki Co Ltd	小球状モノアリルアミン橋かけ重合体の製造方法
US4747881A (en) *	1985-02-05	1988-05-31	Warner-Lambert Company	Ingestible aggregate and delivery system prepared therefrom
US5186937A (en) *	1985-06-07	1993-02-16	A.E.C. Societe De Chimie Organique Et Biologique	Composition for feeding ruminants
IT1190349B (it) *	1986-06-16	1988-02-16	Prodotti Formenti Srl	Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
JPS63218713A (ja) *	1987-02-17	1988-09-12	Daikin Ind Ltd	α−フルオロアクリル酸系重合体ならびに用途
US4837015A (en) *	1987-03-05	1989-06-06	Carolina Medical Products Company, Inc.	Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
GB8817015D0 (en) *	1988-07-16	1988-08-17	Reckitt & Colmann Prod Ltd	Method of treatment
GB8829088D0 (en) †	1988-12-13	1989-01-25	Smith Kline French Lab	Compounds
US5236701A (en) *	1989-07-19	1993-08-17	Lowchol Scientific Inc.	Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
DE3928990A1 (de)	1989-09-01	1991-03-07	Bayer Ag	Verfahren zur herstellung von (alpha)-fluoroacrylsaeurederivaten
US5112993A (en)	1989-11-14	1992-05-12	E. I. Du Pont De Nemours And Company	Process for the preparation of difluoromaleic anhydride
US5091175A (en) *	1990-05-14	1992-02-25	Erbamont Inc.	Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
DE69016014T2 (de) *	1990-07-04	1995-08-31	Marcin Krotkiewski	Blutdrucksenkendes Präparat.
US5162110A (en) *	1990-12-19	1992-11-10	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Binding theophylline to ion exchange resins
US5281631A (en) *	1991-12-20	1994-01-25	Arch Development Corp.	Phosphonic acid based ion exchange resins
EP0565086B1 (en) †	1992-04-10	1996-12-27	Mitsubishi Chemical Corporation	Method for producing a spherical acrylonitrile crosslinked copolymer
RU95107405A (ru) *	1992-08-20	1997-02-10	Е. И. Дюпон Де Немур энд Компани (US)	Сшитая полимерная аммониевая соль, фармацевтическая композиция, способ снижения содержания холестерина в плазме крови, способ усиления экскреции желчных кислот
US5487888A (en) *	1993-05-20	1996-01-30	Geltex, Inc.	Iron-binding polymers for oral administration
US5607669A (en) *	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) *	1994-06-10	1997-04-08	Geltex Pharmaceuticals, Inc.	Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) *	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
EP0730494B1 (en) *	1993-11-25	1998-02-04	Salternate B.V.	Particles for binding monovalent cations and their use
TW474813B (en) *	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
US5824339A (en) *	1995-09-08	1998-10-20	Takeda Chemical Industries, Ltd	Effervescent composition and its production
US6623759B2 (en) *	1996-06-28	2003-09-23	Astrazeneca Ab	Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US5935599A (en) *	1996-10-28	1999-08-10	The Board Of Trustees Of The University Of Illinois	Polymer-associated liposomes for drug delivery and method of manufacturing the same
US6280717B1 (en) *	1998-07-31	2001-08-28	Nikken Chemicals Co., Ltd.	Cation exchange resin preparation
US6294163B1 (en) *	1998-10-02	2001-09-25	Geltex Pharmaceuticals, Inc.	Polymers containing guanidinium groups as bile acid sequestrants
US6558665B1 (en) *	1999-05-18	2003-05-06	Arch Development Corporation	Encapsulating particles with coatings that conform to size and shape of the particles
US20020054903A1 (en) *	1999-10-19	2002-05-09	Joseph Tyler	Direct compression polymer tablet core
US6733780B1 (en) *	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
DE19951116A1 (de)	1999-10-23	2001-04-26	Bosch Gmbh Robert	Relais, insbesondere für eine Startvorrichtung
DE19962935A1 (de) †	1999-12-24	2001-06-28	Bayer Ag	Verfahren zur Herstellung von vernetzten Ionenaustauschern auf Basis von ungesättigten, aliphatischen Nitrilen
AU780873B2 (en) *	2000-01-14	2005-04-21	Otsuka Pharmaceutical Factory, Inc.	Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same
US6994827B2 (en)	2000-06-03	2006-02-07	Symyx Technologies, Inc.	Parallel semicontinuous or continuous reactors
CN1268351C (zh) *	2000-08-01	2006-08-09	奥力榨油化株式会社	糖类吸收抑制剂及其制备方法
JP2004517066A (ja) *	2000-11-20	2004-06-10	ダウグローバルテクノロジーズインコーポレイティド	水吸収性ポリマーの生体内での使用
US7033639B2 (en) *	2001-05-16	2006-04-25	Rohm And Haas Company	Polyaniline coating composition
US6881484B2 (en) *	2001-05-30	2005-04-19	Mitsubishi Kagaku Iatron, Inc.	Core-shell particle including signal-generating substance enclosed therein and process for producing the same
ES2396679T3 (es) *	2003-02-25	2013-02-25	Dupont Nutrition Biosciences Aps	Un sistema de lecho móvil simulado
US7381428B2 (en)	2003-08-26	2008-06-03	Shire International Licensing B.V.	Stabilized lanthanum carbonate compositions
US8282960B2 (en) *	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
CA2557999C (en) *	2004-03-30	2013-11-12	Ilypsa, Inc.	Methods and compositions for treatment of ion imbalances
US7854924B2 (en) *	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
US8192758B2 (en) *	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
US7556799B2 (en)	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
US7429394B2 (en) *	2004-03-30	2008-09-30	Relypsa, Inc.	Ion binding compositions
AU2006299449B2 (en) *	2005-09-30	2013-07-04	Relypsa, Inc.	Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009510233A (ja) *	2005-09-30	2009-03-12	レリプサ，インコーポレイテッド	架橋シェルを有するコア−シェルコンポジットを製造する方法および該方法によって生じたコア−シェルコンポジット
WO2007038801A2 (en) †	2005-09-30	2007-04-05	Ilypsa, Inc.	Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
WO2009029829A1 (en) *	2007-08-29	2009-03-05	Sorbent Therapeutics, Inc.	Polymeric compositions with enhanced saline holding capacity and their method of preparation and use
WO2010022380A2 (en) *	2008-08-22	2010-02-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
US20100111892A1 (en) *	2008-08-22	2010-05-06	Relypsa, Inc.	Crosslinked polyfluoroacrylic acid and processes for the preparation thereof
US20100104527A1 (en) *	2008-08-22	2010-04-29	Relypsa, Inc.	Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
EP3431094B1 (en) †	2008-08-22	2022-12-07	Vifor (International) Ltd.	Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia

2009
- 2009-08-22 EP EP18188764.7A patent/EP3431094B1/en active Active
- 2009-08-22 LT LTEP15171701.4T patent/LT2957286T/lt unknown
- 2009-08-22 US US13/060,207 patent/US20110236340A1/en not_active Abandoned
- 2009-08-22 LT LTEP18188764.7T patent/LT3431094T/lt unknown
- 2009-08-22 GB GB1104561.4A patent/GB2475657B/en active Active
- 2009-08-22 EP EP09748557.7A patent/EP2365988B2/en active Active
- 2009-08-22 SM SM20180660T patent/SMT201800660T1/it unknown
- 2009-08-22 JP JP2011524060A patent/JP5756403B2/ja active Active
- 2009-08-22 ES ES15171701T patent/ES2699494T3/es active Active
- 2009-08-22 PT PT15171701T patent/PT2957286T/pt unknown
- 2009-08-22 PL PL15171701T patent/PL2957286T3/pl unknown
- 2009-08-22 WO PCT/US2009/054706 patent/WO2010022383A2/en not_active Ceased
- 2009-08-22 HR HRP20230091TT patent/HRP20230091T1/hr unknown
- 2009-08-22 PT PT97485577T patent/PT2365988E/pt unknown
- 2009-08-22 DE DE112009002063T patent/DE112009002063T5/de not_active Ceased
- 2009-08-22 BR BRPI0917853A patent/BRPI0917853C1/pt active IP Right Grant
- 2009-08-22 ES ES09748557T patent/ES2545887T5/es active Active
- 2009-08-22 DK DK09748557.7T patent/DK2365988T4/da active
- 2009-08-22 CA CA2735058A patent/CA2735058C/en active Active
- 2009-08-22 MX MX2019004453A patent/MX389664B/es unknown
- 2009-08-22 EP EP22211737.6A patent/EP4201408B1/en active Active
- 2009-08-22 KR KR1020207032030A patent/KR102300471B1/ko not_active Expired - Fee Related
- 2009-08-22 HR HRP20150955TT patent/HRP20150955T1/hr unknown
- 2009-08-22 ES ES22211737T patent/ES3034535T3/es active Active
- 2009-08-22 PL PL09748557T patent/PL2365988T5/pl unknown
- 2009-08-22 GB GB1222750.0A patent/GB2495427B/en active Active
- 2009-08-22 HU HUE18188764A patent/HUE061320T2/hu unknown
- 2009-08-22 HR HRP20250774TT patent/HRP20250774T1/hr unknown
- 2009-08-22 HU HUE09748557A patent/HUE025934T2/en unknown
- 2009-08-22 HU HUE22211737A patent/HUE071829T2/hu unknown
- 2009-08-22 KR KR1020187002772A patent/KR101928973B1/ko active Active
- 2009-08-22 KR KR1020207006869A patent/KR102178208B1/ko active Active
- 2009-08-22 DK DK18188764.7T patent/DK3431094T3/da active
- 2009-08-22 KR KR1020117006635A patent/KR101825113B1/ko not_active Expired - Fee Related
- 2009-08-22 DK DK15171701.4T patent/DK2957286T3/en active
- 2009-08-22 PL PL18188764.7T patent/PL3431094T3/pl unknown
- 2009-08-22 EP EP15171701.4A patent/EP2957286B1/en active Active
- 2009-08-22 ES ES18188764T patent/ES2939021T3/es active Active
- 2009-08-22 CN CN201410106433.5A patent/CN103919792B/zh active Active
- 2009-08-22 PT PT181887647T patent/PT3431094T/pt unknown
- 2009-08-22 SI SI200931889T patent/SI2957286T1/sl unknown
- 2009-08-22 MX MX2015000657A patent/MX364398B/es unknown
- 2009-08-22 CN CN200980137593.3A patent/CN102202670B/zh active Active
- 2009-08-22 PL PL22211737.6T patent/PL4201408T3/pl unknown
- 2009-08-22 KR KR1020187035573A patent/KR102150184B1/ko active Active
- 2009-08-22 AU AU2009282721A patent/AU2009282721B2/en active Active
- 2009-08-22 MX MX2011001893A patent/MX2011001893A/es active IP Right Grant
- 2009-08-22 SI SI200932178T patent/SI3431094T1/sl unknown
- 2009-08-22 FI FIEP18188764.7T patent/FI3431094T3/fi active
2012
- 2012-12-17 GB GB1222752.6A patent/GB2495428A/en not_active Withdrawn
- 2012-12-17 GB GB1222749.2A patent/GB2495426A/en not_active Withdrawn
2014
- 2014-05-12 JP JP2014098677A patent/JP5883471B2/ja active Active
- 2014-05-12 JP JP2014098678A patent/JP2014144978A/ja not_active Withdrawn
2015
- 2015-09-02 SM SM201500207T patent/SMT201500207T1/xx unknown
2016
- 2016-05-12 JP JP2016095867A patent/JP6232468B2/ja active Active
2017
- 2017-02-27 US US15/443,664 patent/US20170165292A1/en not_active Abandoned
- 2017-09-21 JP JP2017181132A patent/JP6633583B2/ja active Active
2018
- 2018-01-15 CY CY2018002C patent/CY2018002I1/el unknown
- 2018-01-15 LT LTPA2018004C patent/LTPA2018004I1/lt unknown
- 2018-01-17 NO NO2018004C patent/NO2018004I1/no unknown
- 2018-11-22 HR HRP20181961TT patent/HRP20181961T1/hr unknown
- 2018-11-29 CY CY20181101268T patent/CY1120930T1/el unknown
- 2018-12-13 LU LU00094C patent/LUC00094I2/fr unknown
- 2018-12-13 LT LTPA2018016 patent/LTC2957286I2/lt unknown
- 2018-12-14 NO NO2018041C patent/NO2018041I1/no unknown
- 2018-12-14 NL NL300962C patent/NL300962I2/nl unknown
- 2018-12-21 JP JP2018238997A patent/JP6890116B2/ja active Active
2019
- 2019-01-09 CY CY2019002C patent/CY2019002I1/el unknown
- 2019-01-15 HU HUS1900003C patent/HUS1900003I1/hu unknown
- 2019-11-01 US US16/672,005 patent/US20200289550A1/en not_active Abandoned
2020
- 2020-07-10 JP JP2020119093A patent/JP2020172537A/ja not_active Withdrawn
2021
- 2021-05-18 US US17/323,627 patent/US20220000906A1/en active Pending

Also Published As

Publication number	Publication date
HRP20150955T1 (hr)	2015-10-09
JP2020172537A (ja)	2020-10-22
ES2545887T3 (es)	2015-09-16
PL2365988T3 (pl)	2015-12-31
KR20180133561A (ko)	2018-12-14
CN102202670B (zh)	2014-04-30
ES2699494T3 (es)	2019-02-11
HK1184675A1 (en)	2014-01-30
LUC00094I2 (pt)	2020-01-23
GB2495428A (en)	2013-04-10
KR20180014845A (ko)	2018-02-09
MX2011001893A (es)	2011-09-27
ES2939021T3 (es)	2023-04-18
BRPI0917853B8 (pt)	2020-04-22
EP3431094A1 (en)	2019-01-23
AU2009282721A1 (en)	2010-02-25
PL3431094T3 (pl)	2023-04-24
JP2017218454A (ja)	2017-12-14
EP2957286A1 (en)	2015-12-23
CY2018002I1 (el)	2019-07-10
WO2010022383A3 (en)	2010-09-23
GB201104561D0 (en)	2011-05-04
DK2957286T3 (en)	2018-12-17
BRPI0917853C1 (pt)	2021-05-25
MX389664B (es)	2025-03-20
PL2957286T3 (pl)	2019-03-29
EP4201408A1 (en)	2023-06-28
GB2475657A (en)	2011-05-25
PT2957286T (pt)	2018-11-30
CY2019002I2 (el)	2020-05-29
PL2365988T5 (pl)	2019-11-29
EP2957286B1 (en)	2018-11-21
KR102150184B1 (ko)	2020-08-31
GB2495427B (en)	2013-08-07
US20200289550A1 (en)	2020-09-17
KR101928973B1 (ko)	2018-12-13
EP4201408B1 (en)	2025-06-25
GB2475657B (en)	2013-05-29
PL4201408T3 (pl)	2025-09-22
GB201222749D0 (en)	2013-01-30
CA2735058A1 (en)	2010-02-25
US20220000906A1 (en)	2022-01-06
JP5883471B2 (ja)	2016-03-15
NO2018041I1 (pt)	2018-12-14
CY2019002I1 (el)	2020-05-29
CY1120930T1 (el)	2020-05-29
EP4201408C0 (en)	2025-06-25
EP2365988A2 (en)	2011-09-21
PT3431094T (pt)	2023-03-03
CN103919792B (zh)	2018-03-09
WO2010022383A2 (en)	2010-02-25
KR20200128600A (ko)	2020-11-13
NL300962I2 (nl)	2020-06-02
LT2957286T (lt)	2018-12-10
HUE071829T2 (hu)	2025-09-28
HUS1900003I1 (hu)	2019-02-28
DK3431094T3 (da)	2023-02-20
JP6890116B2 (ja)	2021-06-18
PT2365988E (pt)	2015-10-22
BRPI0917853B1 (pt)	2020-04-07
AU2009282721B2 (en)	2015-10-29
LTC2957286I2 (lt)	2019-11-25
JP2019065030A (ja)	2019-04-25
LT3431094T (lt)	2023-02-27
JP5756403B2 (ja)	2015-07-29
JP2014144977A (ja)	2014-08-14
JP2014144978A (ja)	2014-08-14
DE112009002063T5 (de)	2012-01-12
GB201222752D0 (en)	2013-01-30
CN103919792A (zh)	2014-07-16
LTPA2018016I1 (lt)	2019-01-10
HUE061320T2 (hu)	2023-06-28
JP6633583B2 (ja)	2020-01-22
JP2012500806A (ja)	2012-01-12
ES3034535T3 (en)	2025-08-19
ES2545887T5 (es)	2020-02-17
DK2365988T3 (en)	2015-10-26
KR101825113B1 (ko)	2018-02-02
US20170165292A1 (en)	2017-06-15
JP6232468B2 (ja)	2017-11-15
LUC00094I1 (pt)	2018-12-19
EP2365988B1 (en)	2015-07-22
EP2365988B2 (en)	2019-07-03
HRP20181961T1 (hr)	2019-02-08
MX364398B (es)	2019-04-24
KR20110063647A (ko)	2011-06-13
KR20200029614A (ko)	2020-03-18
US20110236340A1 (en)	2011-09-29
GB201222750D0 (en)	2013-01-30
EP3431094B1 (en)	2022-12-07
NO2018004I1 (no)	2018-01-17
KR102300471B1 (ko)	2021-09-30
HRP20230091T1 (hr)	2023-03-17
SI2957286T1 (sl)	2018-12-31
GB2495427A (en)	2013-04-10
CA2735058C (en)	2021-01-26
LTPA2018004I1 (lt)	2018-02-12
NL300962I1 (nl)	2018-12-28
SMT201500207T1 (it)	2015-10-30
SMT201800660T1 (it)	2019-01-11
KR102178208B1 (ko)	2020-11-12
CN102202670A (zh)	2011-09-28
JP2016145256A (ja)	2016-08-12
SI3431094T1 (sl)	2023-04-28
FI3431094T3 (fi)	2023-03-20
HRP20250774T1 (hr)	2025-08-29
HUE025934T2 (en)	2016-05-30
GB2495426A (en)	2013-04-10
DK2365988T4 (da)	2019-10-07

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-04-24	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-01-29	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-05-28	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-10-01	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-02-04	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-04-07	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS.
2020-04-22	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: REF. RPI 2570 DE 07/04/2020 QUANTO AO TITULO E PRIORIDADE UNIONISTA.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/08/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2021-08-17	B25A	Requested transfer of rights approved	Owner name: VIFOR ( INTERNATIONAL ) AG (CH)
2022-03-08	B25L	Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled	Owner name: RELYPSA,INC. (US) Free format text: ANULADA A PUBLICACAO CODIGO 25.1 NA RPI NO 2641 DE 17/08/2021 POR TER SIDO INDEVIDA.
2022-03-22	B25A	Requested transfer of rights approved	Owner name: VIFOR (INTERNATIONAL) LTD. (CH)
2022-04-05	B25A	Requested transfer of rights approved	Owner name: VIFOR PHARMA TECHNOLOGY AG (CH)
2022-04-12	B22B	Petition not considered [chapter 22.2 patent gazette]	Free format text: NAO CONHECIDA A PETICAO NO 870210067552, DE 26/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI
2023-07-18	B25A	Requested transfer of rights approved	Owner name: VIFOR (INTERNATIONAL) LTD. (CH)

Publication	Publication Date	Title
BRPI0815708A2 (pt)	2014-09-30	Composto, éster de pró-droga, composição farmacêutica, e, método para tratar uma doença ou condição.
BRPI0907548A2 (pt)	2015-07-28	Sistema e método de rastreamento da zona dental para uma escova de dentes
BRPI0917553A2 (pt)	2015-11-17	método e sistema para extração de gás carbônico por antisublimação sob pressão aumentada
BRPI0807756A2 (pt)	2014-06-17	Método para produzir um l-aminoácido.
BRPI0822052A2 (pt)	2015-07-28	Sistema para preparar uma bebida a partir de ingredientes suportados por uma inserção codificada
BRPI1009390A2 (pt)	2016-03-08	"método e aparelho de associação e manutenção da informação de estado para aplicações."
BRPI0819117A2 (pt)	2018-05-29	sistema de dispensação de composição de combustível, e, método para fornecer uma composição de combustível
BRPI0815318A2 (pt)	2015-02-10	"método e sistema para avaliação de uma condição de um componente".
BRPI0813429A2 (pt)	2017-02-21	sistema e método para uma mbms aperfeiçoada para uma transferência de pss
BRPI0815387A2 (pt)	2017-05-23	composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
BRPI0912830A2 (pt)	2015-10-13	aparelho e método para aliviar obstrução de uma via aérea
BRPI0817672A2 (pt)	2015-03-31	Método e aparelho para produção de ácido acético com purificação aperfeiçoada
FR2914180B1 (fr)	2010-02-12	Cage expansive pour chirurgie vertebrale.
BRPI1006145A2 (pt)	2017-05-30	"composição e método para tratamento de diabetes".
BRPI0716439A2 (pt)	2013-09-17	formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI1014865A2 (pt)	2016-05-03	"composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
BRPI0923508A2 (pt)	2016-01-26	método para a produção de péletes ou briquetes.
BR112012002308A2 (pt)	2016-05-31	dispositivo e método para detectar uma molécula alvo, sistema, e, kit
BRPI0917168A2 (pt)	2015-11-24	sistema e método para detectar uma câmera
BR112012004333A2 (pt)	2015-09-08	composto, composição farmacêutica, e, método para o tratamento ou a prevenção de uma doença ou um distúrbio.
BRPI0719784A2 (pt)	2014-11-25	Processo para preparação de aidas terciárias de ácidos alquilfenilcarboxílicos
BRPI0916167A2 (pt)	2015-07-28	"método para remover contaminantes de caroços de cacau, licor de cacau, produto alimentício e sistema para produzir uma composição contendo cacau"
BRPI0810724A2 (pt)	2014-10-14	Método e sistema para extrair e separar um soluto de uma composição insolúvel.
BRPI1010573A2 (pt)	2016-03-15	aparelho e método para redução de uma matéria-prima sólida.
BRPI0819930A2 (pt)	2016-05-17	composto, éster de pró-droga, composição farmacêutica, e, métodos para tratar uma doença ou condição mediada por sglt e para tratar diabetes